Taysha and Catalent sign commercial manufacturing deal for Rett therapy

Go back to Taysha and Catalent sign commercial manufacturing deal for Rett therapy
(NASDAQ: TSHA) Delayed: 5.04 --0 (-0%)
Previous Close $5.04    52 Week High
Open $5.04    52 Week Low
Day High $5.04    P/E N/A 
Day Low $5.04    EPS
Volume